Posted in | News | Industrial Robotics

Rethink Robotics Closes Series D Financing

Rethink Robotics announced that the company's Series D financing is now closed with the addition of Wellington Management Company LLP joining GE Ventures and Goldman Sachs as significant new investors in the round.

As previously announced, existing investors Bezos Expeditions, CRV, Highland Capital Partners, Sigma Partners, Draper Fisher Jurvetson and Two Sigma Ventures also participated in the $40 million Series D round.  The company announced the first tranche of $26.6M in January and a combination of Wellington Management Company and existing investors contributed the remaining $13.4M in March.  Total investment in the company is now $113.5 million.

The funds will fuel Rethink Robotics' rapid growth and global expansion, and drive product innovations that will continue to raise the bar for collaborative robots in manufacturing. Sawyer, the company's new high-performance, single-arm robot, was introduced last month, to substantial market demand for its ability to perform a variety of precise tasks including machine tending and circuit board testing. All of Rethink's collaborative robots are designed to easily and cost-effectively perform many of the 90% of tasks in factories that are not yet automated.

Since its founding in 2008, Rethink Robotics has consistently set the standard for what smart, collaborative robots can and should do in manufacturing environments. Sawyer, developed for global distribution, significantly expands the addressable market pioneered by Baxter, Rethink's flagship offering, launched in 2012.

"A shortage of manufacturing labor around the world, coupled with manufacturers' need to respond rapidly to market and product changes, is creating the need for a new kind of robot," said Scott Eckert, President and CEO of Rethink Robotics. "The market potential is substantial and our investors are enabling us to lead the way with innovative robots that are transforming global manufacturing."

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.